The varied challenges of psychiatric comorbidities in MS: a perspective from EAN 2019
The association of MS with other conditions is attracting increasing attention among physicians and researchers owing to the effect of comorbidities on important considerations such as time to diagnosis, progression of disability and health-related quality of life (QoL) among patients with MS (pwMS).1 Authors of one recent cohort study in 6,932 pwMS and 68,526 matched controls report
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now